Reuters logo
BRIEF-Valneva receives FDA fast track designation for its lyme disease vaccine candidate VLA15
July 24, 2017 / 5:29 AM / in 3 months

BRIEF-Valneva receives FDA fast track designation for its lyme disease vaccine candidate VLA15

July 24 (Reuters) - VALNEVA SE:

* REG-VALNEVA RECEIVES FDA FAST TRACK DESIGNATION FOR ITS LYME DISEASE VACCINE CANDIDATE VLA15

* COMPLETED PHASE I SUBJECT ENROLLMENT AND EXPECTS TO ANNOUNCE FIRST RESULTS IN Q1 2018

* AIMS TO ACCELERATE VLA15‘S DEVELOPMENT AND PLANS TO INITIATE A PHASE II TRIAL IN Q1 2018

* FAST TRACK DESIGNATION MAY OFFER FASTER WAY TO MARKET APPROVAL THROUGH FREQUENT INTERACTIONS WITH FDA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below